China Shineway Pharmaceutical Group Limited
Research China Shineway Pharmaceutical Group Limited (2877.HK) on Bullrun: market cap HKD 5.62B, P/E 6.3, dividend yield 32.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2877.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 5.62B
- P/E6.3
- Dividend yield32.3%
- Financial periodFY2025
- RevenueCNY 3.14B
- Revenue growth-17.0%
- Net incomeCNY 949.95M
- Free cash flowCNY 974.13M
- Gross margin72.3%
Valuation Snapshot
latest market cap is HKD 5.62B; P/E is 6.3; dividend yield is 32.3%.
Peer valuation comparison
Latest P/E is 6.25x versus a Healthcare sector median of 21.69x (71.2% below).
Latest dividend yield is 32.33% versus a Healthcare sector median of 2.41% (1241.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 3.14B | CNY 949.95M | CNY 974.13M | 72.3% | 1.26 | CNY 7.19B | CNY 334.90M | CNY 8.06B |
| FY2024 | CNY 3.78B | CNY 840.05M | CNY 823.02M | 75.0% | 1.11 | CNY 6.14B | CNY 346.53M | CNY 7.47B |
| FY2023 | CNY 4.52B | CNY 969.51M | CNY 788.31M | 75.1% | 1.28 | CNY 5.89B | CNY 301.33M | CNY 7.03B |
| FY2022 | CNY 3.95B | CNY 722.77M | CNY 980.21M | 74.4% | 0.96 | CNY 5.03B | CNY 7.44M | CNY 6.38B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 5.62B | 6.3 | 19.1% | 1.42 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.42 HKD, yield 32.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.51 CNY |
| FY2024 | 0.58 CNY |
| FY2023 | 0.47 CNY |
| FY2022 | 0.38 CNY |
| FY2021 | 0.72 CNY |
About China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is China Shineway Pharmaceutical Group Limited's market cap?
China Shineway Pharmaceutical Group Limited's market capitalization is HKD 5.62B.
What is China Shineway Pharmaceutical Group Limited's P/E ratio?
China Shineway Pharmaceutical Group Limited's price-to-earnings (P/E) ratio is 6.3.
Does China Shineway Pharmaceutical Group Limited pay a dividend?
China Shineway Pharmaceutical Group Limited has a dividend yield of 32.3%.
What does China Shineway Pharmaceutical Group Limited do?
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong.